Design and SAR study of a novel class of nucleotide analogues as potent anti-HCMV agents

Nucleosides and Nucleotides

Volumn 18, Issue 4-5, 1999, Pages 821-827

  Nguyen Ba, N ^a   Chan, L ^a   Quimpere M ^a   Turcotte, N ^a   Lee, N ^a   Mitchell, H ^a   Bedard J ^a  

^a Shire Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 PHOSPHONATE 1,3 DIOXOLANE NUCLEOTIDE; ANTIVIRUS AGENT; FOSCARNET; GANCICLOVIR; GUANINE DERIVATIVE; LAMIVUDINE; NUCLEOTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; BONE MARROW TOXICITY; CONFERENCE PAPER; DRUG DESIGN; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; HUMAN; HUMAN CYTOMEGALOVIRUS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEPHROTOXICITY; NONHUMAN; VIRUS INFECTION;

ANIMALIA; HUMAN HERPESVIRUS 5;

EID: 0032991958     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/15257779908041570     Document Type: Conference Paper

References (9)

1. rd International Congress on Drug Therapy in HIV Infection", Birmingham, England; published by International Medical Press, 1997.
2. a) Belleau, B.; Dixit, D.; Nguyen-Ba, N.; Kraus, J-J. Abstract of Papers, Fifth International Conference on AIDS, Montreal, Canada 1989, Abstract No. T.C.01, p.215.
3. b) Siddiqui, M.A.; Brown, W.L.; Nguyen-Ba, N.; Dixit, D.M.; Mansour, T.S.; Hooker, E.; Viner, K.C.; Cameron, J.M. Bioorg. Med. Chem. Lett. 1993, 3, 1543-1546.
4. c) Kim, H.O.; Schinazi, R.F.; Nampalli, S.; Shanmuganathan, K.; Cannon, D.L.; Alves, A.J.; Jeong, L.S.; Beach, J.W.; Chu, C.K. J. Med. Chem. 1993, 36, 30-37.
5. Nguyen-Ba, N.; Quimpère, M.; Lee. N.; Mitchell, H. Bioorg. Med. Chem. Lett. Manuscript submitted for publication.
6. During the course of this work Holy et al described a number of related pentofuranosylphosphonates; however they limited their studies to adenine analogues and, except for one example, they focused on nucleotides with the opposite configuration of 10 and 11. None of the compounds demonstrated any antiviral activity against a number of viruses. (i) Otmar, M.; Rosenberg, I.; Masojidkova, M.; Holy, A. Collect. Czech. Chem. Commun. 1993, 58, 2159. (ii) Otmar, M.; Rosenberg, I.; Masojidkova, M.; Holy, A. ibid., 1993, 58, 2180.
7. During the course of this work Holy et al described a number of related pentofuranosylphosphonates; however they limited their studies to adenine analogues and, except for one example, they focused on nucleotides with the opposite configuration of 10 and 11. None of the compounds demonstrated any antiviral activity against a number of viruses. (i) Otmar, M.; Rosenberg, I.; Masojidkova, M.; Holy, A. Collect. Czech. Chem. Commun. 1993, 58, 2159. (ii) Otmar, M.; Rosenberg, I.; Masojidkova, M.; Holy, A. ibid., 1993, 58, 2180.
8. Mattes, H.; Benezra, C. J. Org. Chem., 1988, 53, 2732.
9. Yu, K.L.; Bronson, J.J.; Yang, H.; Patick, A.; Alam, M.; Brankovan, V.; Datema, R.; Hitchcock, M.J.M.; Martin, J.C. J. Med. Chem., 1992, 35, 2958.